Hema Tallman: During IPAW, We Honor The Unseen Heroes – Plasma Donors
Hema Tallman, SVP- Global Head of BioLife Plasma Services at Takeda, reposted from Takeda on LinkedIn:
”During International Plasma Awareness Week, we honor the unseen heroes – plasma donors – and the life-changing impact of their generosity.
The Plasma Protein Therapeutics Association has designated “Plasma Powers Possibility” as this year’s theme, which speaks to the courage of patients and the compassion of those who help them.
At BioLife Plasma Services, our employees know that every donation could mean a better tomorrow for someone who relies on medicine made from plasma.
I want to thank all our employees for their commitment to creating a safe, comfortable, and convenient plasma donation experience for our donors every day.”
Takeda shared on LinkedIn:
”International Plasma Awareness Week (IPAW) is here!
This week, we shine a light on the vital importance of plasma donation, and its life-changing impact on individuals living with rare and serious conditions around the world.
For hundreds of thousands of people globally, medicines made from plasma are essential – and often, their only treatment option.
Plasma’s availability depends on the generosity of donors, making every plasma donation a precious gift.
See plasma’s journey from donor to patient below, and join us in championing this life-sustaining resource.”
Stay updated on the emerging with Hemostasis Today.
-
Oct 7, 2025, 04:20Nita Radhakrishnan to Present The First Indian Collaborative Data on Hemophilia from the WBDR Registry
-
Oct 6, 2025, 04:10EAHAD PT Committee Chair Ruth Elise Is Contributing to The Discussion On Joint Health and Mobility At EHC 2025
-
Oct 6, 2025, 03:44Caitlin Raymond: When We Talk About Plasma Exchange, Most Discussions Stop At What We’re Removing, But That’s Only Half The Story
-
Oct 6, 2025, 03:20Gianluigi Pasta On Cutting-Edge Cartilage Engineering for Bleeding Disorders Community at EHC 2025
-
Oct 5, 2025, 12:02Joseph Raffaele: Everyone Asks Me About Testosterone. Few Ask About DHEA
-
Oct 7, 2025, 03:56Nathan Connell: Interesting Data in The Management of HAC Has Been Published in Blood from Benoit Guillet and Colleagues
-
Oct 7, 2025, 03:40Nature Communications Study by Amelia Haj and Colleagues Identifies Factor XII as a Safer Target for Anticoagulation
-
Oct 7, 2025, 03:36Lisiena Hysenaj: Excited to Announce the Jeroen Roose Lab’s Latest Publication from Laila Karra Khalil
-
Oct 7, 2025, 03:06Ashkan Golshani: A Step Closer to Developing a Therapeutic Against Platelet-type von Willebrand Disease
-
Oct 6, 2025, 03:48New Insights On Pre-Existing AAV5 Abs in Haemophilia B Gene Therapy
-
Oct 7, 2025, 03:502025 Nobel Prize: A Milestone for Autoimmunity Research - Awarded to Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi
-
Oct 3, 2025, 15:31Anirban Sen Gupta and Andrew Shoffstall Collaboration on Bioinspired Synthetic Platelet Systems for Brain Injury Treatment
-
Oct 3, 2025, 15:07Shai Shen-Orr: Excited to Share that The Human Immunome Project (HIP) Has Launched Its Scientific Partner Network
-
Oct 2, 2025, 04:59Caterina Casari - Prizes for Innovators 2025 Winner!
-
Oct 2, 2025, 04:572025 Innovators Award: Ile de France Région Recognizes 3 Researchers Who Have Committed Themselves to The Innovation
-
Oct 7, 2025, 04:35Hema Tallman: During IPAW, We Honor The Unseen Heroes – Plasma Donors
-
Oct 7, 2025, 04:09Svenja Tatjana Barckhausen: Reducing Reliance on U.S. Plasma – Not Just for Europe, But for The World!
-
Oct 7, 2025, 03:58Louise Bannon: Don’t Wait Until You’re Diagnosed to Learn About Blood Clots
-
Oct 6, 2025, 03:57Mattia Galli - Nominated Among The Top 200 of 200,000 Leading Researchers Worldwide for The 2025 USERN Prize!
-
Oct 6, 2025, 03:46Marilena Vrana: I Want to Thank Grifols Deutschland for The Opportunity to Visit Their Premises and Biotest AG Manufacturing Facility in Dreieich